Moxonidine: A new antiadrenergic antihypertensive agent

Journal of Hypertension, Supplement

Volumn 17, Issue 3, 1999, Pages

  Prichard, Brian N C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Haemodynamics; Hypertension; Moxonidine; Pharmacology

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS; MOXONIDINE;

ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ADRENERGIC ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; IMIDAZOLES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 0033176015     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. van Zwieten PA. Centrally acting antihypertensives: a renaissance of interest Mechanisms and haemodynamics. J Hypertens 1997; 15(suppl 1): S3-S8.
2. Julius S. Introduction to the Solvay Symposium. J Hum Hypertens 1997; 11(suppl 1):S1.
3. Mancia G, Di Rienzo M, Parati G, Grassi G. Sympathetic activity, blood pressure variability and end organ damage in hypertension. J Hum Hypertens 1997; 11(suppl 1):S3-S8.